Is KZIA up or down today?
KZIA is down 5.20% today, last at 12.03. This stock moved -5.20% versus the prior close.
KZIA · KZIA
KZIA (KZIA) is trading at 12.03, down 5.20% on the session. Price action shows weakness or stretched conditions worth watching.
Over the past 7 days, 7 headlines skew mixed. Macro/Market and Earnings themes dominated coverage.
Social mentions lean cautious or negative.
Analyst firms are mostly reiterating — no strong directional shift lately.
KZIA is down 5.20% today, last at 12.03. This stock moved -5.20% versus the prior close.
Over the past 7 days, 7 headlines skew mixed. Macro/Market and Earnings themes dominated coverage. Dominant story: Price to sales forward of Kazia Therapeutics Limited – NASDAQ:KZIA - TradingView (1 source, neutral) RSI is 41 — leaning bearish Price below 50-day average — short-term weakness Social (demo): 38% of recent mentions lean bullish — social mood is cautious.
Loaded: Feb 2026 – Jul 2026 (123 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Google Trends data is temporarily unavailable — common on cloud hosts. Search interest is optional context only.
Based on 10,509 mentions over 30d
Price to sales forward of Kazia Therapeutics Limited – NASDAQ:KZIA - TradingView
Kazia Therapeutics Ltd (KZIA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Kazia Therapeutics (NASDAQ: KZIA) files patent backed by TNBC data - Stock Titan
Kazia Therapeutics Announces the Filing of Provisional Patent for Novel Strategy, Supported by Preclinical Data, to Prevent Metastatic Recurrence in Triple-Negative Breast Cancer
Kazia Therapeutics Files Provisional Patent Application Supporting Therapeutic Strategy Designed To Prevent Metastatic Recurrence In Patients With High-Risk Early-Stage Triple-Negative Breast Cancer